Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105545813 | 10554581 | 3 | F | 2004 | 20160714 | 20141030 | 20160722 | EXP | US-009507513-1410USA015393 | MERCK | 0.00 | F | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105545813 | 10554581 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 20560 | 70 | MG | TABLET | /wk | ||||||
| 105545813 | 10554581 | 2 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | 20560 | TABLET | |||||||||||
| 105545813 | 10554581 | 3 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 20560 | 70 | MG | TABLET | /wk | ||||||
| 105545813 | 10554581 | 4 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 0 | 70 | MG | /wk | |||||||
| 105545813 | 10554581 | 5 | SS | ACTONEL | RISEDRONATE SODIUM | 1 | Oral | 35 MG, QW | 0 | 35 | MG | /wk | |||||||
| 105545813 | 10554581 | 6 | C | calcium (unspecified) (+) vitamin D (unspecified) | CALCIUM CARBONATEVITAMIN D | 1 | Unknown | 600 MG/500 IU | 0 | BID | |||||||||
| 105545813 | 10554581 | 7 | C | NIACIN. | NIACIN | 1 | Unknown | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 105545813 | 10554581 | 8 | C | CINNAMON. | CINNAMON | 1 | Unknown | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
| 105545813 | 10554581 | 9 | C | AFLOFARM VITA MINER SENIOR | 2 | Unknown | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 105545813 | 10554581 | 10 | C | OMEGA-3 MARINE TRIGLYCERIDES | FISH OIL | 1 | Unknown | 1000 MG, BID | U | 0 | 1000 | MG | BID | ||||||
| 105545813 | 10554581 | 11 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | 400 IU, BID | 0 | 400 | IU | BID | |||||||
| 105545813 | 10554581 | 12 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Unknown | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
| 105545813 | 10554581 | 13 | C | ZOCOR | SIMVASTATIN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105545813 | 10554581 | 1 | Osteoporosis |
| 105545813 | 10554581 | 2 | Osteopenia |
| 105545813 | 10554581 | 3 | Osteopenia |
| 105545813 | 10554581 | 4 | Osteopenia |
| 105545813 | 10554581 | 5 | Osteopenia |
| 105545813 | 10554581 | 13 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105545813 | 10554581 | HO |
| 105545813 | 10554581 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105545813 | 10554581 | Bone neoplasm | |
| 105545813 | 10554581 | Constipation | |
| 105545813 | 10554581 | Diabetes mellitus | |
| 105545813 | 10554581 | Fall | |
| 105545813 | 10554581 | Femur fracture | |
| 105545813 | 10554581 | Fracture nonunion | |
| 105545813 | 10554581 | Gastrooesophageal reflux disease | |
| 105545813 | 10554581 | Onychomycosis | |
| 105545813 | 10554581 | Osteoporosis | |
| 105545813 | 10554581 | Restless legs syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105545813 | 10554581 | 1 | 200407 | 200802 | 0 | |
| 105545813 | 10554581 | 3 | 200802 | 201010 | 0 | |
| 105545813 | 10554581 | 4 | 200802 | 201010 | 0 | |
| 105545813 | 10554581 | 5 | 200307 | 200407 | 0 | |
| 105545813 | 10554581 | 6 | 2000 | 0 | ||
| 105545813 | 10554581 | 13 | 2001 | 0 |